Logo

American Heart Association

  2
  0


Final ID: 4135873

Time Course of Late Gadolinium Enhancement Intensity in Ventricular Myocardium after Proton Beam Irradiation in Swine

Abstract Body (Do not enter title and authors here): Background: Proton beam irradiation to the ventricular myocardium may enable non-invasive targeting of ventricular tachycardia. Previous work has demonstrated the feasibility of imaging ablation lesion with late gadolinium enhanced (LGE) cardiac magnetic resonance imaging (MRI).

Hypothesis: We hypothesize that proton beam irradiation will lead to progressively increasing density of LGE corresponding to lesion formation during follow-up after treatment delivery.

Aim: The aim of the current study was to determine the time course of LGE intensity in ventricular myocardium following proton beam therapy.

Methods: Eleven swine were irradiated with 40 Gy proton beam in the anterior or lateral left ventricular (LV) followed by LGE cardiac MRI every 4 weeks for up to 24 weeks. After manual contouring of the endocardial and epicardial myocardium, a region of interest (ROI) in the area irradiated with 0-5 Gy was contoured (remote ROI). The mean and standard deviation (SD) of the signal intensity (SI) of the remote ROI were calculated. Light LGE was defined as voxels with SI > mean+2SD but < mean+3SD of the remote ROI, while voxels with SI > mean+3SD of the remote ROI were classified as having dense LGE. Voxels identified as bright due to image artifacts or noise were manually removed. The analysis was conducted in a fashion blinded to swine ID and time point after irradiation.

Results: A total of 33 time points were analyzed (3.1 ± 1.4 MRI studies per swine). Figure 1A shows a representative time course of LGE in the same swine, progressing from diffuse light LGE at 8 weeks to dense LGE at 16-24 weeks. Figure 1B demonstrates the proportion of light versus dense LGE across timepoints in irradiated myocardial regions. At 8 weeks, light and dense LGE areas were evenly distributed. At 12 to 24 weeks, dense LGE increased to approximately 75%. The proportion of dense versus light LGE was significantly higher at 12, 16, and 24 weeks, as compared to 8 weeks.

Conclusion: In ventricular myocardium, diffuse light LGE evident at 8 weeks progresses to denser LGE at 12-24 weeks following proton beam irradiation corresponding with lesion formation.
  • Koya, Taro  ( Mayo Clinic , Rochester , Minnesota , United States )
  • Rettmann, Maryam  ( Mayo Clinic , Rochester , Minnesota , United States )
  • Hirao, Tatsuhiko  ( Mayo Clinic , Rochester , Minnesota , United States )
  • Deisher, Amanda  ( Mayo Clinic , Rochester , Minnesota , United States )
  • Newman, Laura  ( Mayo Clinic , Rochester , Minnesota , United States )
  • Kruse, Jon  ( Mayo Clinic , Rochester , Minnesota , United States )
  • Shumway, Dean  ( Mayo Clinic , Rochester , Minnesota , United States )
  • Merrell, Kenneth  ( Mayo Clinic , Rochester , Minnesota , United States )
  • Packer, Douglas  ( Intermountain Medical Center , Murray , Utah , United States )
  • Siontis, Konstantinos  ( Mayo Clinic , Rochester , Minnesota , United States )
  • Author Disclosures:
    Taro Koya: DO NOT have relevant financial relationships | Maryam Rettmann: DO NOT have relevant financial relationships | Tatsuhiko Hirao: DO NOT have relevant financial relationships | Amanda Deisher: DO NOT have relevant financial relationships | Laura Newman: No Answer | Jon Kruse: No Answer | Dean Shumway: No Answer | Kenneth Merrell: No Answer | Douglas Packer: DO have relevant financial relationships ; Consultant:Biosense Webster:Active (exists now) ; Researcher:EP Limited:Active (exists now) ; Researcher:Siemens AG:Active (exists now) ; Researcher:Cryo Cath:Active (exists now) ; Researcher:Mayo Clinic:Active (exists now) ; Consultant:Impulse Dynamics:Active (exists now) ; Consultant:Neutrace:Active (exists now) ; Consultant:Volta Medical:Active (exists now) ; Consultant:Toray Industries:Active (exists now) ; Consultant:St. Jude Medical:Active (exists now) ; Consultant:Sanofi-Aventis:Active (exists now) ; Consultant:nContact:Active (exists now) ; Consultant:Medtronic:Active (exists now) ; Consultant:CyberHeart:Active (exists now) ; Consultant:Boston Scientific:Active (exists now) | Konstantinos Siontis: No Answer
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Viva Voce! Veritable Voices on VT ablation

Sunday, 11/17/2024 , 09:45AM - 11:00AM

Abstract Oral Session

More abstracts on this topic:
More abstracts from these authors:
Prevalence, Genetic Correlates and Prognostic Significance of an Apical Pseudo-Infarct Late Gadolinium Enhancement Pattern in LMNA-Mediated Cardiac Laminopathy

Castrichini Matteo, Garmany Ramin, Siontis Konstantinos, Ackerman Michael, Giudicessi John

Upgrade to Implantable Cardioverter-Defibrillator in Patients Diagnosed with Cardiac Sarcoidosis after Permanent Pacemaker Implantation for High-Grade Atrioventricular Block

Austin Brett, Rosenbaum Andrew, Abou-ezzeddine Omar, Giudicessi John, Bois John, Bratcher Melanie, Kapa Suraj, Deshmukh Abhishek, Siontis Konstantinos

You have to be authorized to contact abstract author. Please, Login
Not Available